Last reviewed · How we verify

NCT05314777

Efficacy of Extracorporeal Shock Wave Therapy in Carpal Tunnel Syndrome

Status unknown NA Last updated 2 June 2022
What this trial tests

NA trial testing Low dose ESWT application in Carpal Tunnel Syndrome in 60 participants. Status unknown.

Timeline
30 May 2022
Primary endpoint
20 August 2022
20 December 2022

Quick facts

Lead sponsorUniversity of Beykent
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingnone
Primary purposeprevention
Enrollment60
Start date30 May 2022
Primary completion20 August 2022
Estimated completion20 December 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

University of Beykent

Who can join

Adults 18 to 65, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to examine the effects of ESWT applications at different pulse rates on pain, function, grip strength and median nerve conduction velocity in patients with Carpal Tunnel Syndrome. The patients will be randomly divided into 3 groups: the low dose ESWT group (28), the high dose ESWT group (28), and the control group (28). The first two groups will receive ESWT treatment at different doses, while the control group will be treated with sound only (1 time/week-3 weeks).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other University of Beykent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05314777.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing